AAFAQUE AHMAD KHAN, PH.D.

Proteomics and bioinformatics scientist with 10+ years of experience in LC-MS MS based proteomics, DIA workflows, and multi-omics integration within clinical and translational research environments. Proven expertise in developing machine learning models, building bioinformatics pipelines, and leading end-to-end omics projects from experimental design to data interpretation. Strong background in biomarker discovery, high-throughput proteomics platforms, and […]
MAKARY NASSER
Biochemical Engineer and environmental sustainability researcher with 4+ years of experience in applied research, environmental remediation and decarbonization technologies, data analysis, regulatory compliance review, and technical program delivery. Proven ability to manage partner deliverables, verify technical data, write clear reports and correspondence, and present complex results to internal, regulatory, and external stakeholders.
Gwang Jin (Josephus) Kim
Senior Data Scientist computational biologist PhD Molecular Medicine with long-term experience delivering end-to-end analytics across disease research and Pharma Biotech environments from multi-omics single-cell bulk RNA-seq ChIP/ATAC to applied ML CNNs sequence models and robust reproducible pipelines. Clinical-facing background from a university hospital setting Freiburg Germany worked with patient-derived cohort data under ethics approval informed […]
Garima Dixit, MS, PhD, MBA

➤Clinical trial data management and data integrity specialist with 13 years of experience supporting regulated research and industry‑sponsored oncology imaging trials across academic and clinical environments. ➤I help early‑stage biotech, sponsors, and CRO teams ensure accurate, inspection‑ready clinical trial data through hands‑on support in clinical data mining, EMR–EDC traceability, source‑to‑CRF reconciliation, query review and resolution, […]
MEHDI SOLEYMANI-GOLOUJEH, Ph.D.

Postdoctoral scientist with 2+ years of post-PhD experience designing and characterizing engineered human pluripotent stem cell lines at the UCSF Diabetes Center. Applies CRISPR/Cas9-based genome engineering, HDR-oriented knock-in/knockout strategies, TALEN-related workflows, and lentiviral effector systems to build hPSC-derived models of inflammation-driven cell death, with multi-lineage differentiation experience relevant to neural and microglial lineage workflows used […]